Phase III Study of Edasalonexent in Boys With Duchenne Muscular Dystrophy

NCT03703882 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

131

Enrollment

INDUSTRY

Sponsor class

Conditions

Muscular Dystrophy, Duchenne

Interventions

DRUG: Edasalonexent
DRUG: Placebo

Sponsor

Catabasis Pharmaceuticals